risk factor (1, 2) , although this remains controversial (3, 4) . If suboptimal 25(OH)D influences CVD risk, it likely does so predominantly by elevating established CVD risk factors, namely hypertension (5), diabetes (6) , and inflammation (7) . Although several studies have explored associations of 25(OH)D with risk of coronary heart disease (CHD) and stroke (1) , much less is known about associations between 25(OH)D and incidence of heart failure (HF) (8, 9) .
If an association between 25(OH)D and HF exists, it
is unclear whether it varies by race or ethnicity.
Relative to whites, blacks have low 25(OH)D levels but paradoxically higher bone density and lower fracture risk (10) . Additionally, there is some suggestion that associations of low 25(OH)D with risk of diabetes (11) , peripheral artery disease (12) , stroke (13) , and CHD (14) are stronger in whites than blacks.
However, prior studies of other CVD phenotypes were often limited in that they were cross-sectional and/or had limited power for race-and ethnicity-stratified for the C-reactive protein and serum albumin assays were donated by the manufacturers. Genotyping was supported through the National Heart, Lung, and Blood Institute CARe (Candidate Gene Resource) grant (N01-HC-65226). Dr. Lutsey has received grant support from the National Institutes of Health National Heart, Lung, and Blood Institute (R01 HL103706) and the National Institutes of Health Office of Dietary Supplements (R01 HL103706-S1). Dr. Selvin has received grant support from the National for measurement (n ¼ 1,097 Prevalent HF was defined for exclusion by any of the following: an affirmative response to "Were any of the medications you took during the last 2 weeks for heart failure?," stage 3 or "manifest heart failure"
by Gothenburg criteria ( 
RESULTS
The analytic sample of 12,215 participants was on average 57 years old, 24% were black, 56% were female, 34% had prevalent hypertension, and 5% had prevalent CHD. Race-stratified associations between serum 25(OH)D levels and potential covariates are presented in Figures 1A and 1B ) and shown in Table 2 . As shown in Figure 1A , among whites there seemed to be a threshold effect whereby HF risk was increased at 25(OH)D levels below 20 ng/ml, but at levels above 20 ng/ml risk was constant. In multivariable analyses ( Figure 1B ).
There was no evidence of interaction in the asso- Frequencies of key DBP gene polymorphisms varied by race. Among whites for rs7041 the G allele frequency was 56%, whereas in blacks it was 16%. For rs4588 the A allele frequency was 28% in whites and 10% in blacks. Table 3 , Figure 2 , and Online Table 3 ; note the different referent categories for Model 1 adjusted for age (years) and sex. Analyses of the full cohort are also adjusted for race. Model 2 adjusted for model 1 þ educational attainment, physical activity (Baecke sport activity index), smoking status (current, former, never), and body mass index (kg/m 2 ). Model 3 adjusted for model 2 þ prevalent diabetes, hypertension medication use, systolic blood pressure, LDL cholesterol, HDL cholesterol, cholesterol medication use, and hs-CRP. *1 SD ¼ 8.53 ng/ml. †Unadjusted incidence rate per 1,000 person-years.
Abbreviations as in Table 1 .
Lutsey et al. Model 2 adjusted for age (years), sex, educational attainment, physical activity (Baecke sport activity index), smoking status (current, former, never), and body mass index (kg/m 2 ). Analyses of the full cohort are also adjusted for race. Available in Online Table 3 : model 1 (age-, sex-, and where appropriate race-adjusted) and model 3 (cardiovascular disease risk factor adjusted).
Lutsey et al. There are no prior studies of 25(OH)D and HF incidence in blacks with which to compare our findings. However, similar race interactions between 25(OH)D and incidence of other CVD outcomes have been reported (13, 14) . We did not observe an interaction between rs4588 and 25(OH)D on risk of incident HF. However, power was lower because the rs4588 A allele frequency is only 28% in whites and 10% in blacks, and each copy of the A allele is associated with a more modest increase in levels of DBP (w55 mg/ml), relative to each copy of the rs7041 G allele (w189 mg/ml) (15) .
To our knowledge, no other study has assessed whether DBP SNPs modify the association between 25(OH)D and cardiovascular risk. One prior study evaluated the main effect between DBP, SNPs and stroke risk, but found no association (27) . is not presently recommended for CVD prevention (4); our results suggest that were it recommended, a "one dose fits all" approach may be inappropriate.
Supplementation, if recommended, would likely only benefit those who are deficient, and levels of bioavailable D may need to be taken into account.
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